Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Phyllis I. Warkentin"'
Autor:
Pranav S. Renavikar, Phyllis I. Warkentin, Shelly M. Williams, Krishna Gundabolu, Charles Branson, Scott A. Koepsell
Publikováno v:
Stem Cell Research & Therapy, Vol 15, Iss 1, Pp 1-3 (2024)
Abstract Collection of hematopoietic progenitor cell products [HPC(A)] is deferred if the donor is symptomatic and tests positive for Covid-19. However, donor questionnaires are subjective and may miss minimally symptomatic donors. Alternatively, mya
Externí odkaz:
https://doaj.org/article/b6ab05a651394a7d9578e3abb4b0dc72
Publikováno v:
Cytotherapy. 23:886-893
Cell and gene therapy is a promising and disruptive new field of medicine for diseases lacking effective treatments. Collaboration among stakeholders has become critically important as investigators, health care providers, manufacturers, couriers, da
Autor:
Miguel Angel Diaz, Jane L. Liesveld, Ibrahim Ahmed, Jack W. Hsu, Raquel M. Schears, Hillard M. Lazarus, Sachiko Seo, Michael A. Pulsipher, Hemant S. Murthy, Richard F. Olsson, Gregory A. Hale, Soyoung Kim, Siddhartha Ganguly, John R. Wingard, Peiman Hematti, Dennis L. Confer, Galen E. Switzer, Thomas R. Spitzer, Amir Steinberg, Phyllis I. Warkentin, Kimberly A. Kasow, Nirali N. Shah, Jennifer A. Sees, Rammurti T. Kamble, Brent R. Logan, Bronwen E. Shaw, Michele W. Sugrue, Bipin N. Savani, Melhern Solh, Paulo N. Anderlini, Saurabh Chhabra, Christopher E. Dandoy, Nosha Farhadfar, Muneer H. Abidi, Christopher Bredeson, Usama Gergis
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:1210-1217
Peripheral blood stem cells (PBSCs) have been increasingly used for allogeneic hematopoietic cell transplantation instead of bone marrow stem cells. Current National Marrow Donor Program policy recommends 5 days of daily filgrastim, followed by eithe
Autor:
A. Samer Al-Homsi, Phyllis I. Warkentin, Dennis A. Gastineau, Judy M. Anderson, Kamar Godder, Charles F. LeMaistre, Luke P. Akard, Kara K. Wacker, Alan K. Leahigh, Amir Steinberg, Michael Lill, George B. Selby
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:2243-2250
The rapid evolution of blood and marrow transplantation (BMT), coupled with diverse outcomes associated with heterogeneous groups of patients, led to the formation of 2 important organizations early in the development of the field: the Center for Int
Autor:
Phyllis I. Warkentin
Publikováno v:
Cell Therapy ISBN: 9783030755355
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9339a3be63b71aec7ef0b2844103734
https://doi.org/10.1007/978-3-030-75537-9_35
https://doi.org/10.1007/978-3-030-75537-9_35
Autor:
Peter F. Coccia, Phyllis I. Warkentin, Warren G. Sanger, James L. Wisecarver, Sachit Patel, James Harper, Bruce Geoffrey Gordon, Don W. Coulter, Alfred C. Grovas
Publikováno v:
Journal of Pediatric Hematology/Oncology
Juvenile myelomonocytic leukemia (JMML) is a rare mixed myelodysplastic and myeloproliferative clonal disorder of early childhood representing about 1% to 2% of all pediatric leukemias.1–3 Most cases present before 6 years of age, with a median age
Autor:
J. Senesac, James E. Talmadge, Samuel J. Pirruccello, H. Julius, Phyllis I. Warkentin, Ibrahim Younos, Dumrul Gülen, S. Maas, Holly C. Britton
Publikováno v:
International Immunopharmacology. 13:61-68
In this study, we examined the effects of cryoprotectant, freezing and thawing, and adenovirus (Adv) transduction on the viability, transgene expression, phenotype, and function of human dendritic cells (DCs). DCs were differentiated from cultured pe
Autor:
James C. Lynch, Lynette M. Smith, Phyllis I. Warkentin, Adrianna Vlachos, Michael M. Henry, Lauren Harrison, Thomas G. Gross, Mitchell S. Cairo, Sherrie L. Perkins, Amanda Termuhlen, Richard E. Harris
Publikováno v:
Biology of Blood and Marrow Transplantation. 17:249-258
This prospective study was designed to determine the safety and efficacy of cyclophosphamide, BCNU, and etoposide (CBV) conditioning and autologous peripheral blood stem cell transplant (PBSCT) in children with relapsed or refractory Hodgkin and non-
Autor:
Alfred C. Grovas, Elizabeth I. Thompson, Phyllis I. Warkentin, Peter F. Coccia, Terrence L. Zach, Burak Gumuscu
Publikováno v:
Journal of Pediatric Hematology/Oncology. 35:570-572
A now 10-year-old Laotian female was delivered at 30-week gestation by cesarean section because of severe hydrops. Fetal blood sampling revealed homozygous α-thalassemia. After immediate resuscitation, the infant was supported with frequent red cell
Autor:
Fran Rabe, Pat Distler, Ineke Slaper-Cortenbach, Zbigniew M. Szczepiorkowski, Adrian P. Gee, Paul Ashford, Kathy Loper, Leigh Poston, Stella Larsson, Alan Lankester, Derwood Pamphilon, Phyllis I. Warkentin, Irene Feller
Publikováno v:
Bone Marrow Transplantation. 40:1085-1090
The publication of new standards for terminology and labeling marks an important step in ensuring consistency and traceability of cellular therapies at the global level. However, it is only with the widespread implementation of the standard that the